company background image
LNA

LNA SantéENXTPA:LNA Stock Report

Market Cap

€497.4m

7D

-2.1%

1Y

13.3%

Updated

24 Sep, 2021

Data

Company Financials +
LNA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health3/6
Dividends0/6

LNA Overview

LNA Santé SA engages in the management and operation of health establishments.

LNA Santé Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LNA Santé
Historical stock prices
Current Share Price€52.00
52 Week High€43.00
52 Week Low€58.80
Beta0.77
1 Month Change-5.46%
3 Month Change-0.95%
1 Year Change13.29%
3 Year Change-2.62%
5 Year Change58.06%
Change since IPO394.30%

Recent News & Updates

Shareholder Returns

LNAFR HealthcareFR Market
7D-2.1%-1.6%0.7%
1Y13.3%10.9%40.1%

Return vs Industry: LNA exceeded the French Healthcare industry which returned 10.9% over the past year.

Return vs Market: LNA underperformed the French Market which returned 40.1% over the past year.

Price Volatility

Is LNA's price volatile compared to industry and market?
LNA volatility
LNA Beta0.77
Industry Beta0.98
Market Beta1

Stable Share Price: LNA is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: LNA's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19906,323Jean Sirethttps://www.lna-sante.com

LNA Santé SA engages in the management and operation of health establishments. The company operates nursing homes, follow-up care and rehabilitation facilities, home hospitalization structures, health centers, and psychiatric clinics. It serves patients with complex, acute, and chronic pathologies comprising cardiovascular, neurological, and locomotor disorders.

LNA Santé Fundamentals Summary

How do LNA Santé's earnings and revenue compare to its market cap?
LNA fundamental statistics
Market Cap€497.37m
Earnings (TTM)€16.44m
Revenue (TTM)€633.74m

30.2x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LNA income statement (TTM)
Revenue€633.74m
Cost of Revenue€425.68m
Gross Profit€208.06m
Expenses€191.62m
Earnings€16.44m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.72
Gross Margin32.83%
Net Profit Margin2.59%
Debt/Equity Ratio222.5%

How did LNA perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

12%

Payout Ratio

Valuation

Is LNA Santé undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: LNA (€52) is trading below our estimate of fair value (€104.64)

Significantly Below Fair Value: LNA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: LNA is good value based on its PE Ratio (30.2x) compared to the French Healthcare industry average (34.4x).

PE vs Market: LNA is poor value based on its PE Ratio (30.2x) compared to the French market (21.1x).


Price to Earnings Growth Ratio

PEG Ratio: LNA is poor value based on its PEG Ratio (1.2x)


Price to Book Ratio

PB vs Industry: LNA is overvalued based on its PB Ratio (2.5x) compared to the FR Healthcare industry average (2.2x).


Future Growth

How is LNA Santé forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

25.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: LNA's forecast earnings growth (25% per year) is above the savings rate (0.4%).

Earnings vs Market: LNA's earnings (25% per year) are forecast to grow faster than the French market (11.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LNA's revenue (7.7% per year) is forecast to grow faster than the French market (6.3% per year).

High Growth Revenue: LNA's revenue (7.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LNA's Return on Equity is forecast to be low in 3 years time (14%).


Past Performance

How has LNA Santé performed over the past 5 years?

-9.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: LNA has a large one-off loss of €14.3M impacting its June 30 2021 financial results.

Growing Profit Margin: LNA's current net profit margins (2.6%) are higher than last year (2.3%).


Past Earnings Growth Analysis

Earnings Trend: LNA's earnings have declined by 9.4% per year over the past 5 years.

Accelerating Growth: LNA's earnings growth over the past year (31.2%) exceeds its 5-year average (-9.4% per year).

Earnings vs Industry: LNA earnings growth over the past year (31.2%) underperformed the Healthcare industry 31.2%.


Return on Equity

High ROE: LNA's Return on Equity (8.4%) is considered low.


Financial Health

How is LNA Santé's financial position?


Financial Position Analysis

Short Term Liabilities: LNA's short term assets (€299.3M) do not cover its short term liabilities (€499.0M).

Long Term Liabilities: LNA's short term assets (€299.3M) do not cover its long term liabilities (€777.2M).


Debt to Equity History and Analysis

Debt Level: LNA's debt to equity ratio (222.5%) is considered high.

Reducing Debt: LNA's debt to equity ratio has reduced from 247.5% to 222.5% over the past 5 years.

Debt Coverage: LNA's debt is well covered by operating cash flow (24.1%).

Interest Coverage: LNA's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balance Sheet


Dividend

What is LNA Santé current dividend yield, its reliability and sustainability?

0.38%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: LNA's dividend (0.38%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.28%).

High Dividend: LNA's dividend (0.38%) is low compared to the top 25% of dividend payers in the French market (3.93%).


Stability and Growth of Payments

Stable Dividend: LNA is not paying a notable dividend for the French market, therefore no need to check if payments are stable.

Growing Dividend: LNA is not paying a notable dividend for the French market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: LNA is not paying a notable dividend for the French market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LNA's dividend in 3 years as they are not forecast to pay a notable one for the French market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.3yrs

Average board tenure


CEO

Jean Siret (70 yo)

29.17yrs

Tenure

€339,000

Compensation

Mr. Jean paul siret has been the Chairman and Chief Executive Officer of le noble-age., since july 30, 1992. He also serves as Founder of LNA Santé SA. Mr. Siret served as the chief executive officer of sa...


CEO Compensation Analysis

Compensation vs Market: Jean's total compensation ($USD396.96K) is about average for companies of similar size in the French market ($USD501.32K).

Compensation vs Earnings: Jean's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: LNA's board of directors are considered experienced (8.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

LNA Santé SA's employee growth, exchange listings and data sources


Key Information

  • Name: LNA Santé SA
  • Ticker: LNA
  • Exchange: ENXTPA
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €497.366m
  • Shares outstanding: 9.56m
  • Website: https://www.lna-sante.com

Number of Employees


Location

  • LNA Santé SA
  • 7 Boulevard Auguste Priou
  • PO Box 32336
  • Vertou
  • Pays de la Loire
  • 44120
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/24 22:58
End of Day Share Price2021/09/24 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.